Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects

NCT01136317 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Gastroesophageal Reflux

Interventions

DRUG: Omeprazole
DRUG: Rabeprazole
DRUG: Lactose

Sponsor

Nantes University Hospital